Pandemic

Moderna Inc (NASDAQ: MRNA) does not plan to share the formula for making its COVID-19 vaccine, Chairman Noubar Afeyan said in a recent interview with the Associated Press. What Happened: Afeyan told the Press that Moderna executives have come to the conclusion that ramping up production is the best...

National Institutes of Health Director Francis Collins plans to step down by the end of the year, the agency announced Tuesday. What Happened: Collins has served three decades at the NIH and has headed it for over 12 years. He is the longest-serving presidentially appointed NIH director. “It...

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine’s effectiveness against the disease wanes with time but its protection against hospitalization remains, as per a study. What Happened: The vaccine’s effectiveness declined from a peak of 88% a...

Pfizer Inc (NYSE: PFE) says it has begun late-stage testing for an oral drug that can be taken by persons who are exposed to the virus that causes COVID-19. What Happened: The New York-based drugmaker said Monday it has commenced a new large study that will evaluate a novel protease inhibitor...

Pfizer Inc (NYSE: PFE) CEO Albert Bourla said that there is a likelihood that annual booster shots of the coronavirus vaccine will be needed. What Happened: Bourla said in an interview with ABC’s “This Week” program that the COVID-19 vaccine could morph into an annual shot. ...

The U.S. Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer Inc. (NYSE: PFE)-BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine for people aged 65 years and older as well as other high-risk Americans. What Happened: The FDA said that the booster dose can be administered to...

Pfizer Inc (NYSE: PFE) expects to apply for U.S. authorization of its COVID-19 vaccine for children aged six months and five years in November, the Financial Times reported. What Happened: Pfizer Chief Financial Officer Frank D’Amelio told an industry conference organized by Morgan...

The pandemic devastated much of the world. The human cost was high: about 2 million people worldwide died in 2020 and the death toll continues to rise this year. A new report by the Brookings Institute demonstrates that economies were not spared either, as a 3.3% decline occurred...

Moderna Inc (NASDAQ: MRNA) is pushing ahead for authorization of a third shot of its COVID-19 vaccine as a booster. What Happened: The Massachusetts-based company said in a statement Wednesday that it had initiated its submission to the U.S. Food and Drug Administration for evaluation of a booster...

Moderna Inc (NASDAQ: MRNA) shares closed almost 3% lower in the regular session on Monday. What’s Moving? The decline in Moderna shares comes as the U.S. Centers for Disease Control and Prevention explores if a third shot of the COVID-19 vaccine should be provided to the masses. On Monday,...

More than a million doses of Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine have been taken out of circulation in Japan after reports of contamination emerged, Nikkei Asia reported Wednesday. What Happened: Nearly 1.6 million doses were put out of use in Japan, as per the country’s...

Salesforce.com, Inc (NYSE: CRM) CEO Marc Benioff said Wednesday that some fellow corporate executives have been surprised by employees wanting to continue working from home, CNBC reported. What Happened: Benioff made his comments to television host Jim Cramer on “Mad Money” shortly...

One of the major lifestyle trends emerging from the pandemic has been movement out of cities to smaller suburban or rural locations. U.S. Postal Service change-of-address data showed that in the February – July 2020 period, New York City saw a 487% increase over 2019 in a change of address...

The U.S. Food and Drug Administration is expected to authorize on Thursday a third dose of the Pfizer Inc. (NYSE: PFE)-BioNTech SE (NASDAQ: BNTX) and Moderna Inc. (NASDAQ: MRNA) COVID-19 vaccines for certain people with weakened immune systems, the New York Times reported. What Happened: The...

Novavax, Inc (NASDAQ: NVAX) shares closed 12.24% higher in the regular session on Monday. What Happened: The biotechnology company working on a COVID-19 vaccine saw its shares move 0.74% higher in the after-hours trading. The New York State Common Retirement Fund, the third-largest public pension...